Peter Zhang, MD

IM PGY-2 @NYULH_DeptofMed @BellevueHosp | SKMC ‘23

[Robert Zhang MD @robertshiuzhang]

🚨Our new study in @ESC_Journals #EHJACVC examines the impact of large-bore mechanical thrombectomy on PVR in acute PE! 🫁🫀
🔗 https://t.co/XiFkqybZZm
@SripalBangalore @CardsNYC @peter_szz

[Robert Zhang MD @robertshiuzhang]

✅out our latest📜🔍in @CRM! In an IPTW analysis, LBMT was associated with better outcomes vs AC alone in intermediate-risk PE pts assessed by local PERT. The CPES score may help identify pts most likely to benefit from LBMT.
@SripalBangalore @CardsNYC
🔗https://t.co/iCqds6aOhP

[Robert Zhang MD @robertshiuzhang]

Accompanying editorial on our latest publication exploring the relationship between syncope and acute PE! 🔎📜@AmJCardio @ShubhaPawar
🔗https://t.co/llKHkEsOrB

[Peter Zhang, MD @peter_szz]

@JasonKatzMD @robertshiuzhang @CardsNYC @jameshorowitzmd Definitely! We may have been underpowered to detect a difference. Also important caveat is we only looked at syncope on presentation — there was a reasonable delay between presentation and PAC, so can’t comment on the implication of acute syncope in the acute setting.

[Peter Zhang, MD @peter_szz]

Syncope is a common clinical presentation, but whether it portends worse cardiac index / invasive hemodynamics at the time of intervention for PE patients remains unknown. Our group studied that! Check it out: https://t.co/hi6yxImoXm

@robertshiuzhang @CardsNYC @jameshorowitzmd

[NYULangonePCCSM @NYULangonePCCSM]

🔬 From our multidisciplinary teams @bellevuehosp & @nyulangone: Comparing Real-World Outcomes of Catheter-Directed Thrombolysis & Catheter-Based Thrombectomy in Acute #PulmonaryEmbolism: A Post PEERLESS Analysis in @ccijournal

🔒 https://t.co/V676BvfOyB
#Cardiology #PERT #PCCM

[Peter Zhang, MD @peter_szz]

Door-to-balloon ➡️➡️ “door-to-RV unload time” for PE - curious to see what future studies show for this question @CardsNYC @NYULangonePCCSM @NYULH_DeptofMed

[Robert Zhang MD @robertshiuzhang]

Curious about the impact of "door-to-RV unload time" in PE treated w/ percutaneous interventions? Dive into our latest article in @CircIntv to find out👇
🔗https://t.co/cxvKHZVCod
& don't miss the insightful editorial by @sanjum ⤵️
🔗https://t.co/nWlaVGfnay
@SripalBangalore

[Robert Zhang MD @robertshiuzhang]

Curious about the impact of "door-to-RV unload time" in PE treated w/ percutaneous interventions? Dive into our latest article in @CircIntv to find out👇
🔗https://t.co/cxvKHZVCod
& don't miss the insightful editorial by @sanjum ⤵️
🔗https://t.co/nWlaVGfnay
@SripalBangalore

[Robert Zhang MD @robertshiuzhang]

In @ccijournal, we examine real-world outcomes of CDT vs CBT in acute PE, placing our findings in the context of the recently published #PEERLESS trial

🔗https://t.co/VYag7wXuIA

@SripalBangalore @CardsNYC @jameshorowitzmd @btaslakianMD @peter_szz @PERTConsortium

[Eugene Yuriditsky @CardsNYC]

How do you use echo to predict normotensive shock in PE?

We show the TAPSE/PASP ratio is extremely sensitive and specific.

Right Ventricular-Pulmonary Arterial Uncoupling as a Predictor of Inva... https://t.co/YiPSOsiUvK

[Robert Zhang MD @robertshiuzhang]

📢How are you risk stratifying your pts with intermediate risk PE? Have you considered using the CPES score? ✅out our latest 📜 in @CircIntv showing that the CPES score predicts adverse outcomes in PE.
🔗https://t.co/X3bv4d3JLu
@SripalBangalore @SVRaoMD @CardsNYC
A short 🧵 ⤵️

[Robert Zhang MD @robertshiuzhang]

📢I'm excited to share our 📃showing🚫difference in ☠️🪦between housestaff vs APP-based teams in the CCU, & the educational exp for housestaff ⬆️⬆️after implementation of an APP-based team.
🔗https://t.co/iKAaaeypRE
@carlosalviar @JasonKatzMD @JACCJournals @SripalBangalore

[Robert Zhang MD @robertshiuzhang]

✅out recent 📄 demonstrating that ⬆️⬆️ IVC reflux is associated with a ⬇️ cardiac index in acute PE. IVC reflux, obtained at time of CTPE, can be a valuable tool for immediate risk stratification in these pts
https://t.co/sPsgVocfHN
@CardsNYC @SripalBangalore @ThrombosisRese1

[Peter Zhang, MD @peter_szz]

Check out the latest from NYU cardiology and @NYULH_DeptofMed! Excited to see how PE management and risk stratification continue to evolve. Grateful as always for the opportunities and awesome mentors & leaders @robertshiuzhang @CardsNYC @SripalBangalore

[Robert Zhang MD @robertshiuzhang]

📢How are you risk stratifying your pts with intermediate risk PE? Have you considered using the CPES score? ✅out our latest 📜 in @CircIntv showing that the CPES score predicts adverse outcomes in PE.
🔗https://t.co/X3bv4d3JLu
@SripalBangalore @SVRaoMD @CardsNYC
A short 🧵 ⤵️

[MyJSCAI @MyJSCAI]

📣#PulmonaryEmbolism Featured Abstract at #SCAI2024:

💡Comparing Management Strategies in Patients With Clot-in-Transit

➡️https://t.co/JEzdoY0TRP

@CardsNYC @LindsayElbaum @itsradu @TomMaldonadoMD @saricmu @carlosalviar @jameshorowitzmd @SripalBangalore